HIF1A and adrenal cortex carcinoma: Even though advances over the past few decades in several biomarkers associated with metastasis, prognosis, and survival in ACC patients have led to a better understanding of its molecular genetics, the specific effects of HIF-1 activity in ACC and hypoxia signatures for predicting ACC prognosis have not been established (124).